Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

The approval by the FDA of minocycline hydrochloride modified release capsules, also known as DFD-29, will allow for treatment of inflammatory lesions and erythema among adults.

FDA Approves Minocycline Hydrochloride Extended Release Capsules for Individuals with Rosacea 

Del Rosso reviews several key highlights from his Maui Derm presentation on acne and rosacea updates from 2024.

Acne and Rosacea Updates 2024, with James Del Rosso, DO

A post-AAD 2024 discussion on the importance of tailoring acne and rosacea management to individual patients’ needs, focusing more attention on diverse skin types and backgrounds.

Andrew F. Alexis, MD, MPH: Discussing Controversies in Acne, Rosacea 

In this interview with Dr. Baldwin, she spoke on her team’s recent research and its application to rosacea and other dermatologic conditions.


Hilary Baldwin, MD: Present and Future Rosacea Treatment Options

In another segment of her interview with HCPLive, Graber explored some of the latest treatment developments for acne and rosacea covered in her 2023 Winter Clinical Miami presentation.


Emmy M. Graber, MD, MBA: The Present and Future of Acne, Rosacea Treatment

In an HCPLive interview on her Winter Clinical Miami presentation, Graber describes several new developments in the dermatology space regarding acne and rosacea treatments.


Emmy M. Graber, MD, MBA: New Developments in Acne, Rosacea Treatment

An interview segment on HCPLive with James Del Rosso, DO, in which he explores key highlights from his presentation at the 2023 Winter Clinical conference.

James Q. Del Rosso, DO: What’s New for Acne, Rosacea Treatment

In a segment of his HCPLive interview regarding his Winter Clinical presentation, James Del Rosso, DO, highlighted several points about acne and rosacea treatment.

James Q. Del Rosso, DO: Key Points from Presentation on Acne, Rosacea

EPSOLAY is the first and only micro-encapsulated benzoyl peroxide topical treatment  shown to improve inflammatory lesions associated with rosacea

FDA Approves First Topical Rosacea Treatment with Microencapsulated BPO

Botulin toxin was first approved by the FDA in 2002 for cosmetic reasons.

Botulin Toxin Aids in Treating Acne, Rosacea

On the HCPLive rosacea page, resources on the topics of medical news and expert insight into acne rosacea can be found. Content includes articles, interviews, videos, podcasts, and breaking news on the skin condition, and more.